Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Multi-residue analysis of 44 pharmaceutical compounds in environmental water samples by solid-phase extraction coupled to liquid chromatography-tandem mass spectrometry.

Miossec C, Lanceleur L, Monperrus M.

J Sep Sci. 2019 May;42(10):1853-1866. doi: 10.1002/jssc.201801214. Epub 2019 Apr 1.

PMID:
30884137
2.

Reaching the WHO target of testing persons in jails in prisons will need diverse efforts and resources.

Abel S, Cuzin L, Da Cunha S, Bolivard JM, Fagour L, Miossec C, Pircher M, Thioune M, Césaire R, Cabié A.

PLoS One. 2018 Aug 30;13(8):e0202985. doi: 10.1371/journal.pone.0202985. eCollection 2018.

3.

Angiostrongylus costaricensis infection in Martinique, Lesser Antilles, from 2000 to 2017.

Dard C, Nguyen D, Miossec C, de Meuron K, Harrois D, Epelboin L, Cabié A, Desbois-Nogard N.

Parasite. 2018;25:22. doi: 10.1051/parasite/2018022. Epub 2018 Apr 10.

4.

New Surge of Syphilis among Patients Living with Human Immunodeficiency Virus in Martinique in 2015.

Putot A, Rozé B, Pierre-François S, Pircher M, Vilain R, Miossec C, Desbois N, Hochedez P, Guitteaud K, Laudarin I, Abel S, Cabié A.

Am J Trop Med Hyg. 2017 Sep;97(3):923-926. doi: 10.4269/ajtmh.16-0760. Epub 2017 Aug 18.

5.

Protection of Hamsters from Mortality by Reducing Fecal Moxifloxacin Concentration with DAV131A in a Model of Moxifloxacin-Induced Clostridium difficile Colitis.

Burdet C, Sayah-Jeanne S, Nguyen TT, Miossec C, Saint-Lu N, Pulse M, Weiss W, Andremont A, Mentré F, de Gunzburg J.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e00543-17. doi: 10.1128/AAC.00543-17. Print 2017 Oct.

6.

[Clustered cases of histoplasmosis due to Histoplasma capsulatum var. capsulatum in Martinique: Case reports and environmental investigation].

Minoza A, Zecler J, Miossec C, Quist D, Pierre-François S, Deligny C, Simon S, Aznar C, Desbois N.

J Mycol Med. 2016 Dec;26(4):377-384. doi: 10.1016/j.mycmed.2016.09.001. Epub 2016 Oct 7. French.

PMID:
27727098
7.

Multidrug-Resistant Escherichia coli in Bovine Animals, Europe.

Brennan E, Martins M, McCusker MP, Wang J, Alves BM, Hurley D, El Garch F, Woehrlé F, Miossec C, McGrath L, Srikumar S, Wall P, Fanning S.

Emerg Infect Dis. 2016 Sep;22(9):1650-2. doi: 10.3201/eid2209.160140.

8.

Phaeohyphomycosis Caused by a Novel Species, Pseudochaetosphaeronema martinelli.

Ahmed SA, Desbois N, Quist D, Miossec C, Atoche C, Bonifaz A, de Hoog GS.

J Clin Microbiol. 2015 Sep;53(9):2927-34. doi: 10.1128/JCM.01456-15. Epub 2015 Jul 1.

9.

In vitro antibacterial activity of the ceftazidime-avibactam combination against enterobacteriaceae, including strains with well-characterized β-lactamases.

Levasseur P, Girard AM, Miossec C, Pace J, Coleman K.

Antimicrob Agents Chemother. 2015 Apr;59(4):1931-4. doi: 10.1128/AAC.04218-14. Epub 2015 Jan 12.

10.

[Uncommon alopecic plaque].

Le Govic Y, Miossec C, Courdurié C, Desbois N.

J Mycol Med. 2014 Dec;24(4):356-8. doi: 10.1016/j.mycmed.2014.10.012. Epub 2014 Nov 22. French. No abstract available.

PMID:
25454477
11.

First case of visceral leishmaniasis caused by Leishmania martiniquensis.

Liautaud B, Vignier N, Miossec C, Plumelle Y, Kone M, Delta D, Ravel C, Cabié A, Desbois N.

Am J Trop Med Hyg. 2015 Feb;92(2):317-9. doi: 10.4269/ajtmh.14-0205. Epub 2014 Nov 17.

12.

Efficacy of a Ceftazidime-Avibactam combination in a murine model of Septicemia caused by Enterobacteriaceae species producing ampc or extended-spectrum β-lactamases.

Levasseur P, Girard AM, Lavallade L, Miossec C, Pace J, Coleman K.

Antimicrob Agents Chemother. 2014 Nov;58(11):6490-5. doi: 10.1128/AAC.03579-14. Epub 2014 Aug 18.

13.

A 43-year-old Brazilian man with a chronic ulcerated lesion.

Cheuret M, Miossec C, Milley S, Couppie P, Blanchet D, Aznar C.

Clin Infect Dis. 2014 Jul 15;59(2):264, 314-5. doi: 10.1093/cid/ciu379. No abstract available.

PMID:
24973424
14.

Activities of ceftazidime and avibactam against β-lactamase-producing Enterobacteriaceae in a hollow-fiber pharmacodynamic model.

Coleman K, Levasseur P, Girard AM, Borgonovi M, Miossec C, Merdjan H, Drusano G, Shlaes D, Nichols WW.

Antimicrob Agents Chemother. 2014 Jun;58(6):3366-72. doi: 10.1128/AAC.00080-14. Epub 2014 Mar 31.

15.

The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β-lactamase in Enterobacter cloacae.

Miossec C, Claudon M, Levasseur P, Black MT.

Infect Drug Resist. 2013 Dec 3;6:235-40. doi: 10.2147/IDR.S53874. eCollection 2013.

16.

Anti-anaerobic activity of a new β-lactamase inhibitor NXL104 in combination with β-lactams and metronidazole.

Dubreuil LJ, Mahieux S, Neut C, Miossec C, Pace J.

Int J Antimicrob Agents. 2012 Jun;39(6):500-4. doi: 10.1016/j.ijantimicag.2012.02.013. Epub 2012 Apr 20.

PMID:
22521766
17.

In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates.

Levasseur P, Girard AM, Claudon M, Goossens H, Black MT, Coleman K, Miossec C.

Antimicrob Agents Chemother. 2012 Mar;56(3):1606-8. doi: 10.1128/AAC.06064-11. Epub 2012 Jan 3.

18.

Ovarian reserve in young women of reproductive age with Crohn's disease.

Fréour T, Miossec C, Bach-Ngohou K, Dejoie T, Flamant M, Maillard O, Denis MG, Barriere P, Bruley des Varannes S, Bourreille A, Masson D.

Inflamm Bowel Dis. 2012 Aug;18(8):1515-22. doi: 10.1002/ibd.21872. Epub 2011 Sep 20.

PMID:
21936034
19.

Fatal invasive infection with fungemia due to Microascus cirrosus after heart and lung transplantation in a patient with cystic fibrosis.

Miossec C, Morio F, Lepoivre T, Le Pape P, Garcia-Hermoso D, Gay-Andrieu F, Haloun A, Treilhaud M, Leclair F, Miegeville M.

J Clin Microbiol. 2011 Jul;49(7):2743-7. doi: 10.1128/JCM.00127-11. Epub 2011 May 4.

20.

Mechanistic studies of the inactivation of TEM-1 and P99 by NXL104, a novel non-beta-lactam beta-lactamase inhibitor.

Stachyra T, Péchereau MC, Bruneau JM, Claudon M, Frère JM, Miossec C, Coleman K, Black MT.

Antimicrob Agents Chemother. 2010 Dec;54(12):5132-8. doi: 10.1128/AAC.00568-10. Epub 2010 Oct 4.

21.

In vitro activity of the {beta}-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases.

Stachyra T, Levasseur P, Péchereau MC, Girard AM, Claudon M, Miossec C, Black MT.

J Antimicrob Chemother. 2009 Aug;64(2):326-9. doi: 10.1093/jac/dkp197. Epub 2009 Jun 2.

22.

NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.

Livermore DM, Mushtaq S, Warner M, Miossec C, Woodford N.

J Antimicrob Chemother. 2008 Nov;62(5):1053-6. doi: 10.1093/jac/dkn320. Epub 2008 Aug 9.

PMID:
18689875
23.

Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases.

Black MT, Stachyra T, Platel D, Girard AM, Claudon M, Bruneau JM, Miossec C.

Antimicrob Agents Chemother. 2008 Sep;52(9):3339-49. doi: 10.1128/AAC.00496-08. Epub 2008 Jul 14.

24.

Enzymatic activity of two caspases related to interleukin-1beta-converting enzyme.

Fassy F, Krebs O, Rey H, Komara B, Gillard C, Capdevila C, Yea C, Faucheu C, Blanchet AM, Miossec C, Diu-Hercend A.

Eur J Biochem. 1998 Apr 1;253(1):76-83.

25.

Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation.

Miossec C, Dutilleul V, Fassy F, Diu-Hercend A.

J Biol Chem. 1997 May 23;272(21):13459-62.

26.

Evidence for an interleukin-1beta converting enzyme (ICE)-like activity distinct from ICE and responsible for ICE and CPP32 cleavage during apoptosis.

Miossec C, Dutilleul V, Durand L, Faucheu C, Pilatre L, Golec J, Fassy F, Diu-Hercend A.

Apoptosis. 1997;2(2):125-35.

PMID:
14646547
27.
28.

A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells.

Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Hervé F, Collard-Dutilleul V, Gu Y, Aldape RA, Lippke JA, et al.

EMBO J. 1995 May 1;14(9):1914-22.

29.

Characterization of the lymphocyte activation gene 3-encoded protein. A new ligand for human leukocyte antigen class II antigens.

Baixeras E, Huard B, Miossec C, Jitsukawa S, Martin M, Hercend T, Auffray C, Triebel F, Piatier-Tonneau D.

J Exp Med. 1992 Aug 1;176(2):327-37.

30.

CD3.TCR1, a human CD3 epitope expressed on viable gamma/delta lymphocytes exclusively.

Miossec C, Genevee C, Hercend T, Jitsukawa S.

Cell Immunol. 1992 Mar;140(1):173-83.

PMID:
1371241
31.

Molecular characterization of human T cell receptor alpha chains including a V delta 1-encoded variable segment.

Miossec C, Caignard A, Ferradini L, Roman-Roman S, Faure F, Michalaki H, Triebel F, Hercend T.

Eur J Immunol. 1991 Apr;21(4):1061-4.

PMID:
1826885
32.

T cell target 1 (TCT.1): a novel target molecule for human non-major histocompatibility complex-restricted T lymphocytes.

Mami-Chouaib F, Miossec C, Del Porto P, Flament C, Triebel F, Hercend T.

J Exp Med. 1990 Oct 1;172(4):1071-82.

33.

The gamma/delta T cell receptor expressed on human peripheral blood lymphocytes.

Faure F, Miossec C, Jitsukawa S, Triebel F, Hercend T.

Eur Cytokine Netw. 1990 May-Jun;1(2):65-9. Review. No abstract available.

PMID:
1966379
34.

Further analysis of the T cell receptor gamma/delta+ peripheral lymphocyte subset. The V delta 1 gene segment is expressed with either C alpha or C delta.

Miossec C, Faure F, Ferradini L, Roman-Roman S, Jitsukawa S, Ferrini S, Moretta A, Triebel F, Hercend T.

J Exp Med. 1990 Apr 1;171(4):1171-88.

35.

CD1c as a target recognition structure for human T lymphocytes: analysis with peripheral blood gamma/delta cells.

Faure F, Jitsukawa S, Miossec C, Hercend T.

Eur J Immunol. 1990 Mar;20(3):703-6.

PMID:
1690662
36.

Regulatory effects of IgG-BF on hybridoma B cells. molecular characterization of variant cell lines.

Brunati S, Miossec C, Mathiot C, Moncuit J, Amigorena S, Teillaud JL, Fridman WH.

Mol Immunol. 1988 Nov;25(11):1133-42.

PMID:
2975759

Supplemental Content

Loading ...
Support Center